Axsome Therapeutics Inc (GB:0HKF)

Axsome Therapeutics (0HKF) Balance Sheet


Axsome Therapeutics Balance Sheet

Axsome Therapeutics's total assets for Q2 2023 were $611.64M, an increase of 57.45% from the previous quarter. GB:0HKF total liabilities were $332.83M for the fiscal quarter, a 20.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 331.48M$ 87.79M$ 186.13M$ 220.55M$ 15.38M
Total Liabilities
$ 221.92M$ 72.15M$ 72.34M$ 41.83M$ 14.44M
Total Equity Gross Minority
$ 109.59M$ 15.63M$ 113.79M$ 178.72M$ 937.92K
Total Capitalization
$ 203.82M$ 64.72M$ 162.11M$ 196.06M$ 4.56M
Preferred Stock Equity
Capital Lease Obligations
-$ 620.67K$ 1.80M$ 0.00-
Currency in USD

Axsome Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis